A Study to Assess Anktiva in Patients With Long Covid-19.

Abroad (travel likely)RecruitingPHASE2

Conditions

Long COVID

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of California - San Francisco, San Francisco, California, United States
Contact: Study coordinator (Emily Fehrman) · Emily.Fehrman2@ucsf.edu · (650) 761-2163
Contact: Principal Investigator (Michael Peluso, MD)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Examine Anktiva for the Treatment of COVID-19.

Long COVID · Long COVID Syndrome · Long Covid 19

Abroad (travel likely)RecruitingPHASE2

El Segundo, United States

Antiviral Clinical Trial for Long Covid-19

Long Covid

Abroad (travel likely)RecruitingPHASE2

New York, United States

LIFT: Life Improvement Trial

ME/CFS · Long COVID · PASC

Abroad (travel likely)RecruitingPHASE2

Boston, United States

Effectiveness and Safety of Mesenchymal Stem Cell Therapy in Long COVID Patients

Long COVID · Post-Acute COVID-19 Syndrome

Abroad (travel likely)RecruitingPHASE1, PHASE2

Shanghai, China